雷贝拉唑对不同CXCL16表达水平的HP阳性慢性萎缩性胃炎患者治疗效果的观察  

Therapeutic Effects of Rabeprazole in Patients with HP-Positive Chronic Atrophic Gastritis with Different CXCL16 Expression Levels

作　　者：熊焰 韩庆福 XIONG Yan;HAN Qingfu(Department of Pharmacy,Guiqian International Hospital,Guiyang,Guizhou 550018,China)

机构地区：[1]贵黔国际医院药学部,贵州贵阳550018

出　　处：《中国医药指南》2025年第12期43-46,共4页Guide of China Medicine

摘　　要：目的 探究雷贝拉唑对不同C-X-C趋化因子配体16(CXCL16)表达水平的HP阳性慢性萎缩性胃炎患者治疗效果的观察。方法 回顾性分析贵黔国际医院2022年1月至2023年12月收治105例HP阳性慢性萎缩性胃炎患者为研究对象,按不同CXCL16表达水平分为高表达组(≥2.45μg/L)70例,低表达组(<2.45μg/L)35例,给予雷贝拉唑治疗,对比CXCL16表达水平与胃黏膜病理状态及临床疗效等。结果 ROC曲线显示CXCL16对HP阳性慢性萎缩性胃炎预测价值良好;治疗后高表达组PGⅠ/PGⅡ、PGⅠ水平低于低表达组,炎症因子、CK-MB、胃黏膜病理状态评分、GAS、PGⅡ、血钾、TBIL、AST、ALT、ALB水平高于低表达组(P<0.05);Spearman相关性分析,高、低CXCL16表达水平与治疗效果呈负相关性。结论 雷贝拉唑对不同CXCL16表达水平的HP阳性慢性萎缩性胃炎患者治疗效果显著,能改善患者CXCL16水平,提高机体免疫力。Objective To investigate the therapeutic effect of rabeprazole in patients with HP-positive chronic atrophic gastritis with different C-X-C chemokine ligand 16(CXCL16)expression levels.Methods A retrospective analysis of 105 patients with HP-positive chronic atrophic gastritis admitted to Guijian International Hospital from January 2022 to December 2023 was selected as the study objects.According to different CXCL16 expression levels,70 cases were divided into a high expression group(≥2.45μg/L)and 35 cases were divided into a low expression group(<2.45μg/L).Rabeprazole was given treatment.The expression level of CXCL16 was compared with the pathological status and clinical efficacy of gastric mucosa.Results The ROC curve showed that CXCL16 had good predictive value for HP-positive chronic atrophic gastritis;the levels of PGⅠ/PGⅡand PGⅠin the high expression group were lower than those in the low expression group,and the levels of inflammatory factors,CK-MB,gastric mucosal pathological state score,GAS,PGⅡ,blood potassium,TBIL,AST,ALT,and ALB were higher than those in the low expression group after the treatment(P<0.05).Spearman’s correlation analysis showed that the high and low CXCL16 expression levels were negatively correlated with the treatment effect.Conclusions The therapeutic effect of rabeprazole on patients with HP-positive chronic atrophic gastritis with different CXCL16 expression levels was significant,improving the patients’CXCL16 levels and enhancing the body’s immunity.

关 键 词：雷贝拉唑 C-X-C趋化因子配体16 幽门螺杆菌阳性 慢性萎缩性胃炎 

分 类 号：R573.32[医药卫生—消化系统]